- Research works
- 38 ▼ 4% vs 2018-21
- Citations
- 697 18.2 per fractional work
- Top-10% rate
- 29.4% all institutions 10.0%
- Open access
- 34% world 40%
- International
- 46% world 18%
Not ranked overall: Merus (Netherlands) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Merus (Netherlands) work in?
In all years, 56% of research at Merus (Netherlands) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (9%). It does 2.1× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 15 fields, with their numbers
- Health Sciences2256.5%
- Medicine2154.7%
- Health Professions11.7%
- Life Sciences1230.1%
- Physical Sciences410.8%
- Computer Science26.2%
- Engineering12.7%
- Chemistry00.7%
- Environmental Science00.7%
- Mathematics00.6%
- Social Sciences12.6%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.4×. Every wedge is a field page.
All 10 fields, with their numbers
- Immunology and Microbiology7.39×1 works
- Biochemistry, Genetics and Molecular Biology3.86×2 works
- Medicine3.15×7 works
- Neuroscience1.19×0 works
- Health Professions1.10×0 works
- Economics, Econometrics and Finance0.49×0 works
- Computer Science0.41×0 works
- Business, Management and Accounting0.20×0 works
- Social Sciences0.11×0 works
- Engineering0.01×0 works
Who are the top researchers at Merus (Netherlands)?
Ranked on the quality score, John de Kruif, Mark Throsby and Cecile A. W. Geuijen lead among researchers whose main affiliation is Merus (Netherlands).
- 1
John de Kruif
Netherlands · #198,708 worldwide 4.7k citations · 58 works
- 2
Mark Throsby
Netherlands · #406,868 worldwide 4.8k citations · 85 works
- 3
Cecile A. W. Geuijen
Netherlands · #564,801 worldwide 1.7k citations · 53 works
- 4
Ernesto Wasserman
Netherlands · #864,621 worldwide 2.5k citations · 66 works
- 5
Linda J. A. Hendriks
Netherlands · #924,555 worldwide 1.7k citations · 36 works
- 6
Tristan Gallenne
Netherlands · #1,098,552 worldwide 813 citations · 17 works
- 7
Therèse Visser
Netherlands · #1,195,670 worldwide 1.2k citations · 19 works
- 8
Kees Bol
Netherlands · #1,735,290 worldwide 880 citations · 21 works
- 9
Robert P. Doornbos
Netherlands · #3,440,208 worldwide 590 citations · 22 works
Which keywords describe research at Merus (Netherlands)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Chemotherapy, Monoclonal Antibody and Cancer Immunotherapy.
- Recombinant Proteins
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Innate Immunity
- Chimeric Antigen Receptor
- ALK Inhibitors
- Antigen Presentation
- Clinical Trials
- Tumor Microenvironment
- Mobile Application Development
- Immune System
- Immunotherapy
- Tumor Metastasis
- Metastatic
- Cancer Stem Cells
- Epithelial-Mesenchymal Transition
- Cancer Immunotherapy
- Chemotherapy
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Monoclonal Antibody
- Breast Cancer
- Cancer
- HER2
- Trastuzumab
- Targeted Therapy
- Glycans
- Cross-Platform Development
- Tumor Regression
- Biopharmaceuticals
- Immunity
- Lymphoma
- CAR T Cells
- EGFR Mutations
- Dendritic Cells
- Immunogenicity
- Tumor Antigen
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation10▲ 113×3 topics
- Monoclonal Antibodies8▲ 150×3 topics
- Therapeutic Antibodies8▲ 157×2 topics
- Antibody Engineering7▲ 181×1 topic
- Fc Receptors7▲ 181×1 topic
- Chemotherapy3▲ 12×8 topics
- Monoclonal Antibody3▲ 115×2 topics
- Cancer Immunotherapy3▲ 52×2 topics
- Breast Cancer3▲ 25×2 topics
- Epithelial-Mesenchymal Transition3▲ 82×2 topics
- Cancer3▲ 4.8×7 topics
- Cancer Stem Cells3▲ 160×1 topic
- HER23▲ 222×1 topic
- Metastatic3▲ 108×2 topics
- Trastuzumab3▲ 157×1 topic
- Tumor Metastasis3▲ 114×1 topic
- Targeted Therapy2▲ 30×5 topics
- Immunotherapy2▲ 9.1×6 topics
- Glycans2▲ 68×1 topic
- Immune System2▲ 17×1 topic
- Cross-Platform Development2▲ 513×1 topic
- Mobile Application Development2▲ 513×1 topic
- Tumor Regression2▲ 60×2 topics
- Tumor Microenvironment2▲ 14×4 topics
- Biopharmaceuticals2▲ 63×3 topics
- Clinical Trials2▲ 6.6×5 topics
- Immunity2▲ 12×3 topics
- Antigen Presentation2▲ 39×2 topics
- Lymphoma2▲ 26×2 topics
- ALK Inhibitors1▲ 67×1 topic
- CAR T Cells1▲ 86×1 topic
- Chimeric Antigen Receptor1▲ 86×1 topic
- EGFR Mutations1▲ 67×1 topic
- Innate Immunity1▲ 10×2 topics
- Dendritic Cells1▲ 30×1 topic
- Immune Checkpoint Blockade1▲ 58×1 topic
- Immunogenicity1▲ 67×2 topics
- PD-1 and PD-L11▲ 58×1 topic
- Tumor Antigen1▲ 43×1 topic
- Recombinant Proteins1▲ 57×2 topics
Which research topics does Merus (Netherlands) publish most on?
By volume in 2022-now: Cancer Cells and Metastasis, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Cells and Metastasis Oncology 2 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 5 CAR-T cell therapy research Oncology 1 works
- 6 Cancer Research and Treatments Biotechnology 0 works
- 7 HER2/EGFR in Cancer Research Oncology 0 works
- 8 Immunotherapy and Immune Responses Immunology 0 works
- 9 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
- 10 Medical Device Sterilization and Disinfection Microbiology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Merus (Netherlands)'s research output changed?
Output in 2022-2025 was 4% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Merus (Netherlands) as a percentage of every work published that year, 0.000017% in 2024.
Fractional works of Merus (Netherlands) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Utrecht
- Utrecht University
- Rutgers Sexual and Reproductive Health and Rights
- Huisarts en Wetenschap
- Wilhelmina Children's Hospital
- University of Applied Sciences Utrecht
- Geneeskundige en Gezondheidsdienst
- Oncode Institute
- University of Humanistic Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Merus (Netherlands). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.